ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
BINDING AFFINITY;
CONTROLLED STUDY;
DRUG BINDING SITE;
DRUG EFFECT;
DRUG RECEPTOR BINDING;
DRUG STRUCTURE;
FEMALE;
NONHUMAN;
OOCYTE;
POINT MUTATION;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
VOLTAGE CLAMP;
XENOPUS LAEVIS;
In vivo determination of efficacy of pyrazoloquinolinones at the benzodiazepine receptor
Brown C, Martin I, Jones B, Oakley N, (1984). In vivo determination of efficacy of pyrazoloquinolinones at the benzodiazepine receptor. Eur J Pharmacol 103: 139-143.
He X, (2000). Studies of Molecular Pharmacophore/Receptor Models for GABAA/BZR Subtypes: Chemical and Computer Assisted Approach in Search of Selective Ligands for GABAA/BZR Subtypes, PhD Thesis, UW-Milwaukee, USA.
A/BzR alpha2beta3gamma2, alpha3beta3gamma2 and alpha4beta3gamma2 recombinant subtypes. Included volume analysis and comparison to alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2 subtypes
A/BzR alpha2beta3gamma2, alpha3beta3gamma2 and alpha4beta3gamma2 recombinant subtypes. Included volume analysis and comparison to alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2 subtypes. Drug Des Discov 17: 131-171.
35S]TBPS binding to the chloride channel. Noncompetitive inhibition of classical benzodiazepines and competitive inhibition of the partial agonist, CGS 9895, by CGS 8216
35S]TBPS binding to the chloride channel. Noncompetitive inhibition of classical benzodiazepines and competitive inhibition of the partial agonist, CGS 9895, by CGS 8216. Neuropharmacology 26: 775-778.
A novel GABA(A) receptor pharmacology: Drugs interacting with the alpha+beta-interface
Sieghart W, Ramerstorfer J, Sarto-Jackson I, Varagic Z, Ernst M, (2012). A novel GABA(A) receptor pharmacology: drugs interacting with the alpha+beta-interface. Br J Pharmacol 166: 476-485.
Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux
Smith AJ, Alder L, Silk J, Adkins C, Fletcher AE, Scales T, et al. (2001). Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux. Mol Pharmacol 59: 1108-1118.
Williams M, Bennett DA, Loo PS, Braunwalder AF, Amrick CL, Wilson DE, et al. (1989). CGS 20625, a novel pyrazolopyridine anxiolytic. J Pharmacol Exp Ther 248: 89-96.